NCT05347043
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
- Locations
-
- Internal Medicine Department - Tenon Paris, France
Clinical trial condition
Anemia, Sickle Cell
Explore clinical trials studying Anemia, Sickle Cell. Study availability and eligibility vary by location and protocol.
843 public trials
152 recruiting studies
Anemia, Sickle Cell trial results
NCT03431935
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Methodist Adult Comprehensive Sickle Cell Center Memphis, Tennessee, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Completed
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
NCT01911871
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
- Locations
-
- Hôpital Necker Enfants Malades Paris, France
NCT06561061
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Jinja Hospital Jinja, Uganda
NCT01891812
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
- Locations
-
- New York Presbyterian Morgan Stanley Children's Hospital New York, United States
NCT06835335
- Conditions
- Agnosia, Anemia, Anemia, Hemolytic, +22 more
- Locations
-
- CHU de Nîmes Nîmes, Occitanie, France
- Manchester University NHS FT Manchester, United Kingdom
Completed
L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity
NCT05470998
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Tanta university Tanta, Other (Non U.s.), Egypt
NCT02961218
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Novartis Investigative Site Atlanta, Georgia, United States
- Novartis Investigative Site Augusta, Georgia, United States
- Novartis Investigative Site Greenville, North Carolina, United States
- Novartis Investigative Site Toronto, Ontario, Canada
Completed
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism
NCT03938454
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
- Locations
-
- University Of Alabama Birmingham, Alabama, United States
- University of Connecticut Health Center Farmington, Connecticut, United States
- Childrens National Hospital Washington D.C., District of Columbia, United States
- Foundation for Sickle Cell Disease Research Hollywood, Florida, United States
NCT00012545
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States